2025-05-22 06:01:36 pm | Source: reuters
India`s Sun Pharma posts quarterly profit rise on strong demand for rare disease drugs
Sun Pharmaceutical, India's largest drugmaker by revenue, reported a rise in adjusted quarterly profit on Thursday, driven by strong domestic demand for its drugs to treat rare diseases.
The Mumbai-based firm's consolidated profit before exceptional items and tax rose 24% to 36.16 billion rupees ($420.7 million) in the three months ended March 31.
Disclaimer:
The content of this article is for informational purposes only and should not be considered financial or
investment advice. Investments in financial markets are subject to market risks, and past performance is
not indicative of future results. Readers are strongly advised to consult a licensed financial expert or
advisor for tailored advice before making any investment decisions. The data and information presented
in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the
content of this article for any current or future financial references.
To Read Complete Disclaimer Click Here
Latest News
RBI Monetary Policy Highlights ? Dec`25 by Axis Secu...
MO Advisor - December 2025 by Siddhartha Khemka, Sr....
Focus Investment Ideas: Dec 25 by Motilal Oswal Weal...
India`s export policy sends positive signal to tradi...
Refund in full progress, set to operate 1,650 flight...
Government says no advisory issued to pause financin...
Jan Dhan accounts now hold Rs 2.75 lakh crore
5 top companies add over Rs 72,000 crore in market v...
MF equity investments double in November to Rs 43,46...
Nifty & Bank Nifty Weekly Outlook 07th December 2025...
